Chemotherapy, AdjuvantChemoradiotherapyAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyChemoradiotherapy, AdjuvantRadiotherapy, AdjuvantAdjuvants, ImmunologicFluorouracilNeoplasm StagingCisplatinTreatment OutcomeDisease-Free SurvivalNeoadjuvant TherapyBreast NeoplasmsSurvival AnalysisNeoplasm Recurrence, LocalCyclophosphamideSurvival RateAntineoplastic AgentsPrognosisRectal NeoplasmsFreund's AdjuvantEsophageal NeoplasmsDoxorubicinAntimetabolites, AntineoplasticAdenocarcinomaRadiotherapy DosageCarcinoma, Squamous CellDrug Administration ScheduleLymphatic MetastasisMethotrexateLung NeoplasmsAdjuvants, PharmaceuticTegafurFollow-Up StudiesRadiotherapyKaplan-Meier EstimateHead and Neck NeoplasmsRetrospective StudiesCarboplatinPaclitaxelEsophagectomyDeoxycytidineTaxoidsEpirubicinRad52 DNA Repair and Recombination ProteinCarcinoma, Non-Small-Cell LungNasopharyngeal NeoplasmsLeucovorinLevamisoleOrganoplatinum CompoundsTime FactorsInduction ChemotherapyRandomized Controlled Trials as TopicGastrectomyTamoxifenColonic NeoplasmsAnthracyclinesStomach NeoplasmsVinblastineOxonic AcidMastectomyClinical Trials as TopicNeoplasm MetastasisEtoposideDose FractionationTumor Markers, BiologicalProspective StudiesPneumonectomyLymph Node ExcisionProportional Hazards ModelsAntineoplastic Agents, AlkylatingCystectomyMultivariate AnalysisMitomycinAntineoplastic Agents, HormonalColorectal NeoplasmsPancreatic NeoplasmsCarcinomaDigestive System Surgical ProceduresSarcomaMucositisLymph NodesReceptors, EstrogenUracilIfosfamidePreoperative CareFeasibility StudiesHypopharyngeal NeoplasmsLomustineClinical Trials, Phase III as TopicRecurrenceReceptor, erbB-2Brain NeoplasmsSalvage TherapyPredictive Value of TestsPremenopauseOrgan Sparing TreatmentsPostoperative CarePositron-Emission Tomography